Search research articles
Contact Us
Filters
Showing results (11-20 of 270) with videos related to
Page
of 27
Sort By:
Current Opinion in Pharmacology
|
May 14, 2021
Corrigendum to "Metformin: Still the sweet spot for CV protection in diabetes?" [Curr Opin Pharmacol 54 (2020) 202-208]
Graham Rena, Ify R Mordi, Chim C Lang
Cardiovascular Therapeutics
|
May 20, 2008
Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study
Maheshwar Pauriah, Allan D Struthers, Chim C Lang
Current Heart Failure Reports
|
November 16, 2013
Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failure
Archyut Valluri, Allan D Struthers, Chim C Lang
Cardiac Failure Review
|
June 13, 2018
Iron Therapy in Heart Failure: Ready for Primetime?
Ify R Mordi, Aaron Tee, Chim C Lang
Current Opinion in Pharmacology
|
December 3, 2020
Metformin: still the sweet spot for CV protection in diabetes?
Graham Rena, Ify R Mordi, Chim C Lang
Diseases (Basel, Switzerland)
|
September 22, 2017
Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure
Abbey Steggall, Ify R Mordi, Chim C Lang
Circulation
|
January 21, 2025
SGLT Inhibitors in Persons With Heart Failure and Type 1 Diabetes: Filling the Therapeutic Gap
Ify R Mordi, Rory J McCrimmon, Chim C Lang
Circulation
|
July 19, 2021
Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"
Jagdeep S Singh, Allan D Struthers, Chim C Lang
European Journal of Heart Failure
|
October 9, 2018
What is the added value of the waist-to-hip ratio on top of the BIOSTAT risk prediction model in patients with heart failure? Reply
Koen W Streng, Chim C Lang, Adriaan A Voors
The New England Journal of Medicine
|
October 8, 2015
Ezetimibe plus a Statin after Acute Coronary Syndromes
Jagdeep S Singh, Allan D Struthers, Chim C Lang
Page
of 27
Search research articles
Search
Showing results (11-20 of 270) with videos related to
Sort By:
Page
of 27
Current Opinion in Pharmacology
|
May 14, 2021
Corrigendum to "Metformin: Still the sweet spot for CV protection in diabetes?" [Curr Opin Pharmacol 54 (2020) 202-208]
Graham Rena, Ify R Mordi, Chim C Lang
Cardiovascular Therapeutics
|
May 20, 2008
Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study
Maheshwar Pauriah, Allan D Struthers, Chim C Lang
Current Heart Failure Reports
|
November 16, 2013
Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failure
Archyut Valluri, Allan D Struthers, Chim C Lang
Cardiac Failure Review
|
June 13, 2018
Iron Therapy in Heart Failure: Ready for Primetime?
Ify R Mordi, Aaron Tee, Chim C Lang
Current Opinion in Pharmacology
|
December 3, 2020
Metformin: still the sweet spot for CV protection in diabetes?
Graham Rena, Ify R Mordi, Chim C Lang
Diseases (Basel, Switzerland)
|
September 22, 2017
Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure
Abbey Steggall, Ify R Mordi, Chim C Lang
Circulation
|
January 21, 2025
SGLT Inhibitors in Persons With Heart Failure and Type 1 Diabetes: Filling the Therapeutic Gap
Ify R Mordi, Rory J McCrimmon, Chim C Lang
Circulation
|
July 19, 2021
Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"
Jagdeep S Singh, Allan D Struthers, Chim C Lang
European Journal of Heart Failure
|
October 9, 2018
What is the added value of the waist-to-hip ratio on top of the BIOSTAT risk prediction model in patients with heart failure? Reply
Koen W Streng, Chim C Lang, Adriaan A Voors
The New England Journal of Medicine
|
October 8, 2015
Ezetimibe plus a Statin after Acute Coronary Syndromes
Jagdeep S Singh, Allan D Struthers, Chim C Lang
Page
of 27